Patent · US Active

Modified growth hormone

US7884073B2 · kind B2 · utility

13Cited by

102References

32Claims

0Family size

Assignee

HANALL BIOPHARMA CO., LTD. · KR

Inventors

Thierry Guyon · Palaiseau, FR
Gilles Borrelly · Épinay-sous-Sénart, FR
Lila Drittanti · Vigneux-sur-Seine, FR
Manuel Vega · Vigneux-sur-Seine, FR

Key dates

Filing date	Jun 26, 2006
Grant date	Feb 8, 2011
Priority date	—
Expiry date	Aug 28, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are modified growth hormone polypeptides, nucleic acid molecules encoding modified growth hormone polypeptides and methods of generating modified growth hormone polypeptides. Also provided are methods of treatment using modified growth hormone polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.